Bioqual Statistics
Total Valuation
Bioqual has a market cap or net worth of 31.48 million. The enterprise value is 51.67 million.
| Market Cap | 31.48M |
| Enterprise Value | 51.67M |
Important Dates
The last earnings date was Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Oct 7, 2024 |
Share Statistics
Bioqual has 894,416 shares outstanding.
| Current Share Class | 894,416 |
| Shares Outstanding | 894,416 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.76% |
| Owned by Institutions (%) | n/a |
| Float | 205,671 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.74 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.93 |
| P/FCF Ratio | 5.30 |
| P/OCF Ratio | 5.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.74, with an EV/FCF ratio of 8.70.
| EV / Earnings | -41.82 |
| EV / Sales | 1.22 |
| EV / EBITDA | 9.74 |
| EV / EBIT | n/a |
| EV / FCF | 8.70 |
Financial Position
The company has a current ratio of 4.01, with a Debt / Equity ratio of 0.96.
| Current Ratio | 4.01 |
| Quick Ratio | 3.90 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 6.31 |
| Debt / FCF | 5.64 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -3.47% and return on invested capital (ROIC) is -4.05%.
| Return on Equity (ROE) | -3.47% |
| Return on Assets (ROA) | -2.24% |
| Return on Invested Capital (ROIC) | -4.05% |
| Return on Capital Employed (ROCE) | -3.50% |
| Weighted Average Cost of Capital (WACC) | 1.89% |
| Revenue Per Employee | 374,751 |
| Profits Per Employee | -10,932 |
| Employee Count | 113 |
| Asset Turnover | 0.66 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -309,347 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.00% in the last 52 weeks. The beta is -0.06, so Bioqual's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | -36.00% |
| 50-Day Moving Average | 57.88 |
| 200-Day Moving Average | 74.37 |
| Relative Strength Index (RSI) | 19.27 |
| Average Volume (20 Days) | 730 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioqual had revenue of 42.35 million and -1.24 million in losses. Loss per share was -1.38.
| Revenue | 42.35M |
| Gross Profit | 8.07M |
| Operating Income | -2.29M |
| Pretax Income | -1.54M |
| Net Income | -1.24M |
| EBITDA | -40,381 |
| EBIT | -2.29M |
| Loss Per Share | -1.38 |
Balance Sheet
The company has 13.29 million in cash and 33.48 million in debt, with a net cash position of -20.18 million or -22.57 per share.
| Cash & Cash Equivalents | 13.29M |
| Total Debt | 33.48M |
| Net Cash | -20.18M |
| Net Cash Per Share | -22.57 |
| Equity (Book Value) | 35.02M |
| Book Value Per Share | 39.15 |
| Working Capital | 19.37M |
Cash Flow
In the last 12 months, operating cash flow was 6.28 million and capital expenditures -346,166, giving a free cash flow of 5.94 million.
| Operating Cash Flow | 6.28M |
| Capital Expenditures | -346,166 |
| Depreciation & Amortization | 2.25M |
| Net Borrowing | n/a |
| Free Cash Flow | 5.94M |
| FCF Per Share | 6.64 |
Margins
Gross margin is 19.06%, with operating and profit margins of -5.40% and -2.92%.
| Gross Margin | 19.06% |
| Operating Margin | -5.40% |
| Pretax Margin | -3.65% |
| Profit Margin | -2.92% |
| EBITDA Margin | -0.10% |
| EBIT Margin | -5.40% |
| FCF Margin | 14.02% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.42%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 1.42% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.42% |
| Earnings Yield | -3.92% |
| FCF Yield | 18.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 28, 1997. It was a reverse split with a ratio of 0.16666.
| Last Split Date | Oct 28, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.16666 |
Scores
Bioqual has an Altman Z-Score of 2.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 3 |